Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Liberum Capital Reiterates “Buy” Rating for Udg Healthcare PLC (LON:UDG)
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Other analysts have also recently issued reports about the stock. Peel Hunt boosted their price objective on shares of Udg Healthcare PLC from GBX 730 ($9.53) to GBX 830 ($10.84) and gave the company an add rating in a research note on Tuesday, May 23rd. Numis Securities Ltd reissued a hold rating and set a GBX 730 ($9.53) price objective on shares of Udg Healthcare PLC in a research note on Tuesday, May 23rd. Berenberg Bank cut shares of Udg Healthcare PLC to a hold rating and set a GBX 745 ($9.73) price objective for the company. in a research note on Monday, May 15th. Stifel Nicolaus boosted their price objective on shares of Udg Healthcare PLC from GBX 620 ($8.10) to GBX 650 ($8.49) and gave the company a hold rating in a research note on Tuesday, April 4th. Finally, Jefferies Group LLC cut shares of Udg Healthcare PLC to a hold rating and boosted their price objective for the company from GBX 760 ($9.92) to GBX 785 ($10.25) in a research note on Wednesday, May 24th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of GBX 781.57 ($10.21).
Udg Healthcare PLC (UDG) opened at 839.00 on Tuesday. Udg Healthcare PLC has a 1-year low of GBX 567.00 and a 1-year high of GBX 886.50. The firm’s market capitalization is GBX 2.08 billion. The firm’s 50-day moving average price is GBX 841.24 and its 200-day moving average price is GBX 740.59.
ILLEGAL ACTIVITY WARNING: This story was first reported by [[site]] and is owned by of [[site]]. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at [[permalink]].
The firm also recently announced a dividend, which was paid on Tuesday, June 27th. Investors of record on Thursday, June 1st were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Thursday, June 1st. This represents a dividend yield of 0.35%.
In other Udg Healthcare PLC news, insider Jez Moulding bought 18,000 shares of Udg Healthcare PLC stock in a transaction that occurred on Wednesday, May 31st. The shares were acquired at an average price of GBX 808 ($10.55) per share, for a total transaction of £145,440 ($189,919.04). Also, insider Chris Corbin sold 5,650 shares of Udg Healthcare PLC stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of GBX 827 ($10.80), for a total transaction of £46,725.50 ($61,015.28).
Udg Healthcare PLC Company Profile
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.